The May 25 issue of HemOnc Today includes the annual Oncology Drugs in the Pipeline chart, which lists drugs in phase 2 or phase 3 development for a variety of indications.
To coincide with the publication of the chart, HemOnc Today asked several clinicians to offer their perspectives about the drugs in the pipeline they believe are most promising for their specialties.
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.